• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2感染(COVID-19)与鼻科表现:叙述性综述

SARS-CoV-2 Infection (COVID-19) and Rhinologic Manifestation: Narrative Review.

作者信息

Lee Seung Hoon, Seo Min Young

机构信息

Division of Rhinology, Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Ansan Hospital, Ansan 15355, Korea.

Division of Rhinology, Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul 02841, Korea.

出版信息

J Pers Med. 2022 Jul 28;12(8):1234. doi: 10.3390/jpm12081234.

DOI:10.3390/jpm12081234
PMID:36013183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9409980/
Abstract

Patients with severe pneumonia of unknown etiology presented in December 2019 in Wuhan, China. A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was isolated from the respiratory tracts of these patients. The World Health Organization (WHO) defined respiratory diseases due to SARS-CoV-2 infection as coronavirus disease 2019 (COVID-19). Many researchers have reported that the nasal cavity is an important initial route for SARS-CoV-2 infection and that the spike protein of this virus binds to angiotensin-converting enzyme 2 (ACE2) on epithelial cell surfaces. Therefore, COVID-19 is thought to significantly affect nasal symptoms and various rhinological diseases. In this review, we summarize the association between COVID-19 and various rhinological diseases, such as olfactory dysfunction, rhinosinusitis, and allergic rhinitis.

摘要

2019年12月,中国武汉出现了病因不明的重症肺炎患者。一种新型冠状病毒,即严重急性呼吸综合征冠状病毒2(SARS-CoV-2),从这些患者的呼吸道中分离出来。世界卫生组织(WHO)将SARS-CoV-2感染引起的呼吸道疾病定义为2019冠状病毒病(COVID-19)。许多研究人员报告称,鼻腔是SARS-CoV-2感染的重要初始途径,且该病毒的刺突蛋白与上皮细胞表面的血管紧张素转换酶2(ACE2)结合。因此,COVID-19被认为会显著影响鼻腔症状和各种鼻科疾病。在这篇综述中,我们总结了COVID-19与各种鼻科疾病之间的关联,如嗅觉功能障碍、鼻窦炎和过敏性鼻炎。

相似文献

1
SARS-CoV-2 Infection (COVID-19) and Rhinologic Manifestation: Narrative Review.严重急性呼吸综合征冠状病毒2感染(COVID-19)与鼻科表现:叙述性综述
J Pers Med. 2022 Jul 28;12(8):1234. doi: 10.3390/jpm12081234.
2
Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence.新型冠状病毒病 2019 与鼻部状况:当前证据综述。
In Vivo. 2021 May-Jun;35(3):1409-1417. doi: 10.21873/invivo.12393. Epub 2021 Apr 28.
3
The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.hACE2 受体蛋白的表达及其在 SARS-CoV-2 进入、发病机制中的作用及其作为潜在治疗靶点的应用。
Tumour Biol. 2021;43(1):177-196. doi: 10.3233/TUB-200084.
4
Inflammatory endotypes of CRSwNP and responses to COVID-19.慢性鼻窦炎伴鼻息肉(CRSwNP)的炎症表型与对 COVID-19 的反应。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):8-15. doi: 10.1097/ACI.0000000000000700.
5
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎:分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
6
Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.严重急性呼吸综合征冠状病毒2的潜在发病机制。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):591-597. doi: 10.11817/j.issn.1672-7347.2020.200299.
7
Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice.研发一种新型肽,以防止 SARS-CoV-2 进入表达 hACE2 的肺和嗅球细胞的小鼠。
Mol Brain. 2022 Aug 9;15(1):71. doi: 10.1186/s13041-022-00956-1.
8
Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的出现、演变及疫苗生产方法:接种疫苗的益处及常见问题
Saudi J Biol Sci. 2022 Apr;29(4):1981-1997. doi: 10.1016/j.sjbs.2021.12.020. Epub 2021 Dec 13.
9
The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.新型冠状病毒(SARS-CoV-2)和 COVID-19 疫情。
Int Braz J Urol. 2020 Jul;46(suppl.1):6-18. doi: 10.1590/S1677-5538.IBJU.2020.S101.
10
A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).一种新型的 SARS-CoV-2 刺突蛋白 1 抗原的快速检测方法,利用人血管紧张素转换酶 2(ACE2)。
Biosens Bioelectron. 2021 Jan 1;171:112715. doi: 10.1016/j.bios.2020.112715. Epub 2020 Oct 15.

引用本文的文献

1
Exploring the Preventive Potential of Solubilized Sturgeon Oil on Acute Infection with Respiratory Viruses.探索溶解的鲟鱼油对呼吸道病毒急性感染的预防潜力。
Mar Drugs. 2025 Mar 5;23(3):112. doi: 10.3390/md23030112.
2
Genome-Wide Association Study Meta-Analysis Uncovers Novel Genetic Variants Associated with Olfactory Dysfunction.全基因组关联研究荟萃分析揭示与嗅觉功能障碍相关的新型遗传变异。
medRxiv. 2024 Aug 10:2024.08.09.24311665. doi: 10.1101/2024.08.09.24311665.

本文引用的文献

1
Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.嗅觉训练改良法是治疗新冠病毒引起的嗅觉障碍的有效方法。
Laryngoscope. 2022 Jul;132(7):1433-1438. doi: 10.1002/lary.30101. Epub 2022 Mar 11.
2
Covid-19-Related Acute Invasive Fungal Sinusitis: Clinical Features and Outcomes.新型冠状病毒肺炎相关急性侵袭性真菌性鼻窦炎:临床特征与转归
Int Arch Otorhinolaryngol. 2022 Jan 25;26(1):e152-e157. doi: 10.1055/s-0041-1740947. eCollection 2022 Jan.
3
COVID-19-associated acute invasive fungal sinusitis: Clinical and imaging findings.COVID-19 相关侵袭性真菌性鼻旁窦炎:临床与影像学表现。
J Neuroimaging. 2022 Jul;32(4):676-689. doi: 10.1111/jon.12967. Epub 2022 Jan 18.
4
Do Patients With Chronic Rhinosinusitis Exhibit Elevated Rates of Covid-19 Infection?慢性鼻-鼻窦炎患者的新冠病毒感染率是否升高?
Laryngoscope. 2022 Feb;132(2):257-258. doi: 10.1002/lary.29961. Epub 2021 Nov 27.
5
Impact of quarantine and face masks on ragweed-induced oculorhinits during the COVID-19 pandemic in Northern Italy.意大利北部新冠疫情期间隔离措施和口罩对豚草诱发的鼻眼过敏症的影响
Int Forum Allergy Rhinol. 2022 Feb;12(2):220-222. doi: 10.1002/alr.22889. Epub 2021 Sep 28.
6
COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection.COVID-19 相关头痛和鼻-鼻窦炎炎症:一项纵向研究分析急性鼻-鼻窦炎和 ICHD-3 分类困难在 SARS-CoV-2 感染中的作用。
Cephalalgia. 2022 Mar;42(3):218-228. doi: 10.1177/03331024211040753. Epub 2021 Sep 20.
7
Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms.新冠疫情封锁期间的口罩佩戴与自我报告的季节性过敏性鼻炎症状
Rhinology. 2021 Oct 1;59(5):481-484. doi: 10.4193/Rhin21.202.
8
COVID-19-associated mucormycosis: Case report and systematic review.COVID-19 相关毛霉病:病例报告和系统评价。
Travel Med Infect Dis. 2021 Nov-Dec;44:102148. doi: 10.1016/j.tmaid.2021.102148. Epub 2021 Aug 26.
9
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.口服和鼻用皮质类固醇对新冠病毒嗅觉功能障碍患者的短期疗效和安全性:一项欧洲多中心研究
Pathogens. 2021 Jun 4;10(6):698. doi: 10.3390/pathogens10060698.
10
Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial.糠酸莫米松鼻喷雾剂治疗 COVID-19 嗅觉功能障碍患者的随机、双盲临床试验。
Int Immunopharmacol. 2021 Sep;98:107871. doi: 10.1016/j.intimp.2021.107871. Epub 2021 Jun 12.